Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05048186 · ClinicalTrials.gov registry record
Refining the Shared Decision Making Process Survey in ADHD Medication Decisions
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 512
- Enrollment target
NCT05048186: Completed study, sponsored by Massachusetts General Hospital.
NCT05048186 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 512 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05048186 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 512 participants
- Enrollment target
Study Summary
This is a retrospective observational survey study. We will survey a sample of adult parents or legal guardians who have a child who has been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and who discussed ADHD treatment options for their child with a health care provider within the last 2 years. The main goal is to gather evidence of the validity and reliability of the Shared Decision Making Process scale. Secondary goal is to gather evidence on the quality of decisions parents make about their children with ADHD. A third goal is to assess the impact of a Decision Aid on participant knowledge of ADHD treatment options. Participants will be randomized to one of two arms: participants in the intervention arm will review a Decision Aid (patient educational tool) partway through the survey and those in the control arm will not receive any educational materials. All participants will complete survey that includes the Shared Decision Making process survey along with a few other measures. A subset of respondents will also complete a retest survey about two weeks after the initial survey.
Interventions
- BEHAVIORAL Attention Deficit Hyperactivity Disorder Treatment Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2021-04-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05048186
The ClinicalTrials.gov registry entry for NCT05048186 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 512 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Attention Deficit Hyperactivity Disorder Treatment Decision Aid is the first listed.
NCT05048186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05048186 about?
NCT05048186 is a clinical study titled "Refining the Shared Decision Making Process Survey in ADHD Medication Decisions". This is a retrospective observational survey study. We will survey a sample of adult parents or legal guardians who have a child who has been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and who discussed ADHD treatment options for their child with a health care provider within the...
What is the current status of trial NCT05048186?
This trial is currently completed. The enrollment target is 512 participants. The study started on 2021-02-24. Estimated completion is 2021-04-13.
What interventions are being tested in trial NCT05048186?
The interventions under investigation include: Attention Deficit Hyperactivity Disorder Treatment Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT05048186?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.